Observational studyAllergy2025

Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational study.

Stefania Arasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.